About the Journal
- Aims and Scope
- Editorial Board
- Journal Policy
- Privacy Policy
- Publication Ethics
- Publication Fee
- Open Access Policy
- Peer Review Policy
- Advertising Policy
- AI Policy
Journal Policy
Ensuring that all articles published in Muscles, Ligaments and Tendons Journal (MLTJ) comply with internationally accepted ethical standards is a primary responsibility of the Editors. MLTJ requires that all research involving human participants or animals is conducted in accordance with applicable ethical principles, regulations, and institutional requirements.
The Editors, with the support of peer reviewers, assess the ethical aspects of submitted manuscripts, including the study design and the conduct of the research, to determine whether the methods employed are ethically acceptable. Manuscripts found to involve unethical research practices or to fail to meet accepted ethical standards will be rejected, regardless of the scientific significance or potential impact of their findings.
We require that authors submit a paper providing:
- The name of the approving committee
- Approval number or code protocol
- Date of approval
This kind of information must be provided in the “Materials and methods” paragraph of all works submitted to MLTJ.
The submitted manuscripts must comply with the policies of MLTJ. In case of need, the guidelines based on the Committee on Publication Ethics (COPE) on good publication can be consulted.
Human Rights
The study must be conducted in accordance with the ethical standards established in the Declaration of Helsinki of 1964 (WMA Declaration Of Helsinki – Ethical Principles For Medical Research Involving Human Participants).
Authors must guarantee that the enrolled participants (or those who stand in for – e.g. legal guardians, next of kin in case of death) signed an informed consent and that they are aware they will be part of a scientific publication. All articles containing potentially identifiable material must include a statement confirming that appropriate consent for publication was obtained from the participant(s).
Patients’ names and unnecessary references to personal aspects (e.g., occupation, residence, etc.) or sensitive data (e.g., political preference, etc.) that could reveal the identity of a patient must be omitted from the text and iconographic materials.
Animals Rights
When undertaking animal investigations, the study must have been conducted in accordance with the International Guiding Principles for Biomedical Research Involving Animals for the use of laboratory animals and with local/national guidelines approved by the appropriate committee. The respect for the recommendations must be explicitly stated in the manuscript.
Studies conducted using anaesthesia or euthanasia, in a way incompatible with the commonly accepted norms of veterinary best practice, will not be taken into consideration (see AVMA guidelines for more information).
If a manuscript has been submitted from a country where there is no ethics committee or institutional review board, authors should explain how the study adhered to the World Medical Association Declaration of Helsinki.
Misconduct / Plagiarism
Authors should declare any potentially overlapping publications on submission. Any overlapping publications explicitly identified should be cited.
In case of doubt, the Editors shall require explanations and full access to the used documents, such as the signed consent forms. The Editors can also proceed with an independent revision of the manuscript to ascertain if the manuscript meets the ethical standards. If any problem emerges, the authors and the institution where the study was conducted will be consulted and updated about the results of such a review. The manuscripts could be rejected in case of serious misconduct.
Furthermore, in case of serious proven misconduct, all authors of the indicted article shall be banned from future publication in MLTJ.
Each manuscript submitted to MLTJ is peer reviewed and checked for plagiarism (this involves duplicate submission, self-plagiarism, etc.). However, a fraudulent article or an article previously published elsewhere could be improperly published. In this case, the article will be retracted. Readers will be informed with a notification on the journal website (www.mltj.online), and Editors and/or the Publisher will contact the authors’ institution. In case of publication on indexing systems, every appropriate step to identify the fraudulent article will be undertaken, including adding the word “Retraction” in the title.
Data falsification and fabrication
Data falsification means to manipulate data, images, or not convenient results, with the intention of giving a false impression, for example, increasing the scientific quality of the study.
Any doubt regarding data integrity will be referred to the Editor. The Editor may request the data for inspection or verification. If the original data cannot be provided, the manuscript will be rejected or retracted, depending on the case.
Authorship and contributorship
The corresponding author is responsible for all the information reported in the manuscript, from the list of authors (to prevent ghost/gift-guest authorship) to the availability of data.
The corresponding author should gain consent from all co-authors for the submission of the manuscript. Not gaining consent from each author for submission could lead to involuntary misconduct in the form of duplicate submission (see “Misconduct/Plagiarism” paragraph above).
The involvement of scientific (medical) writers or anyone else who helped with the preparation of the manuscript content should be acknowledged, along with their source of funding.
For more information, visit ICMJE’s webpage.
Manipulation of Images
MLTJ strives to avoid misrepresentation of the data collected. Images cannot be modified (enhancing, obscuring, moving, removing or introducing features) to change the overall appearance or appearance of any specific feature.
Adjustments of brightness and contrast or colour balance are acceptable, but must be applied to the entire image and as long as they do not obscure, eliminate, or misrepresent any information present in the original.
Images collected at different times or from different locations or from different parts of the same gel or from different gels should not be combined into a single image, unless specified. In this case, the edges must be clearly delimited (e.g., dividing lines) in the figure and described in the legend.
For more details, please visit the following websites:
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114110/
- https://www.elsevier.com/connect/authors-update/five-things-every-researcher-should-know-about-image-manipulation
Biosafety and Biosecurity
Every article submitted to MLTJ must be compliant with relevant institutional biosafety and biosecurity protocols/national or international recommendations.
Standards for Research
MLTJ welcomes in vitro and in vivo manuscripts for submission that comply with the following clinical research criteria:
- Adequately controlled (clearly describe the comparison: placebo or conventional medicine use)
- Blinded (where appropriate)
- Randomised
- With sufficient statistical power, depending on the sample size
Suggested Guidelines to Follow According to the Type of Article
MLTJ suggests checking the following guidelines when writing the manuscript:
- Randomized controlled trials (follow CONSORT)
- Systematic reviews and meta-analyses (PRISMA)
- Observational studies (STROBE)
- Diagnostic/prognostic studies (STARD and TRIPOD)
- Pre-clinical animal studies (ARRIVE)
Trial Registration
MLTJ supports registration of clinical trials. The registration number should be included as the last line of the manuscript abstract.
MLTJ adheres to the World Health Organization (WHO) definition of a clinical trial, which is “any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes”. This definition includes phase I to IV trials. Health-related interventions are defined as “any intervention used to modify a biomedical or health-related outcome”, and health-related outcomes are defined as “any biomedical or health-related measures obtained in patients or participants”. Authors could consult the ICMJE FAQs if they are unsure whether their trial needs to be registered.
Suitable publicly available registries are listed on the ICMJE website, as well as the primary registries that participate in the WHO International Clinical Trials Registry Platform.
Examples of public Clinical Trials Registry are:
- http://www.anzctr.org.au
- http://www.clinicaltrials.gov
- http://isrctn.org
- http://www.trialregister.nl/trialreg/index.asp
- http://www.umin.ac.jp/ctr
- https://www.who.int/clinical-trials-registry-platform
MLTJ encourages the publication of study protocols: it reduces the risk of non-publication of research findings and facilitates methodological discussion. If the study protocol for a trial has been published, it should be cited in the manuscript.
For clinical trials that have not been registered prospectively, MLTJ encourages retrospective registration.
MLTJ will consider manuscripts describing retrospectively registered studies.
Protocols of randomized controlled trials should follow the CONSORT extension for abstracts and the CONSORT guidelines.
Registration of Systematic Reviews
MLTJ supports the prospective registration of systematic reviews and encourages authors to register their systematic reviews in a suitable registry (such as PROSPERO). Authors who have registered their systematic review should include the registration number as the last line of the manuscript abstract.
Research Data Policy
MLTJ strongly encourages that all datasets on which the conclusions of the article rely should be available to readers upon request. The authors should provide a link to the repository used to archive the data supporting the results. Authors are required to provide a data availability statement reporting on the availability or the absence of shared data.
Submission of a manuscript to MLTJ implies that any unique materials described in the manuscript will be freely available to scientists wishing to use them for non-commercial purposes.
For datasets containing clinical data, authors have ethical and legal responsibilities to protect the privacy and the identity of participants. Participants, once recruited, should sign an informed consent for the publication of the dataset. In case of impossibility, authors must demonstrate that the publication of data does not compromise the legal rights of participants. Authors must include in their manuscript whether informed consent was obtained for the publication of patient data. If informed consent was not obtained, authors must state the reason.
Third-party data
If a third party is consulted to generate or analyse part or all of the data presented in the study, this aspect should be clearly stated into “Materials and methods” section. If it is not possible, the unavailability should be clearly stated.
Pharmaceutical Companies
If a study has been financed by pharmaceutical companies, the Ethics standards of the Journal, the Author Guidelines and the good publication practice must be followed (read also the updating).
Conflict of Interests
A conflict of interest can be financial or non-financial. It rises when the authors’ interpretation/presentation of data/information may be influenced, or just perceived as influenced, by a personal or financial relationship with other organizations.
All authors are required to disclose any conflicts of interest in the designated section of the manuscript. In addition to this statement, authors must complete the ICMJE Disclosure of Interest form by following this link: https://icmje.org/disclosure-of-interest/ and upload the completed document in the submission system as part of their submission.
Once the article is online, all the declarations will appear on each article, in a specific paragraph entitled Conflict of interests. If authors declare no conflict of interests, a default sentence will be report: “The authors declare that they have no conflict of interests”. In case of conflicts, an ad-hoc sentence will be prepared.
The authors will be held responsible for any false declarations or noncompliance with the instructions specified above.
The Editorial Office reserves the right to reject any manuscript that does not conform to the above-described instructions.
Corrections, Retractions and Editorial Expressions of Concern
MLTJ is committed to maintaining the accuracy, integrity, and transparency of the published records. When significant issues are identified in published contents, the journal may issue a correction, retraction, or editorial expression of concern, depending on the nature and severity of the issue.
Anyone who becomes aware of possible errors or ethical concerns in a published article - including authors, readers, or organizations - is asked to report them initially to the Editorial Office at editorialoffice@mltj.online. The editorial team will evaluate all inquiries and may consult external specialists when deemed necessary to determine the appropriate response, following the guidance set by COPE (Committee on Publication Ethics).
Corrections
Corrections are issued when errors are identified that do not invalidate the overall scientific findings or conclusions of the article. These may include:
- Typographical or formatting errors
- Incorrect author affiliations or acknowledgments
- Minor data or figure inaccuracies
- DErrors introduced during production or publication
Corrections are published promptly, linked to the original article, and indexed.
Retractions
Retractions are issued when a published article is found to contain major errors or breaches of research or publication ethics that invalidate the reliability of the work. Grounds for retraction may include:
- Fabrication or falsification of data
- Plagiarism
- Duplicate publication
- Unethical research practices
- Serious methodological or analytical flaws
Retraction decisions are made following an investigation by the editorial office, in consultation with authors, reviewers, institutions, and relevant ethical guidelines such as those provided by the COPE (Committee on Publication Ethics). Retraction notices remain permanently linked to the original article and indexed. The original article is marked with a retraction watermark, and its title is updated to include the prefix “Retracted:”
Editorial Expressions of Concern
An editorial expression of concern may be issued when:
- Serious concerns have been raised regarding an article,
- An investigation is ongoing, or
- Available evidence is inconclusive but warrants notifying readers.
Expressions of concern are temporary notices intended to maintain transparency while further review is conducted. This approach is recommended by COPE (Committee on Publication Ethics) to keep readers updated during a research integrity investigation.
Investigation Process
All allegations or concerns are assessed confidentially and fairly by the editorial team. The journal follows established publication ethics standards and provides authors with an opportunity to respond before a final decision is made. Where appropriate, institutions or funding bodies may be contacted during the investigation process.
Transparency and Record Integrity
All post-publication notices are made freely accessible, clearly identified, and permanently linked to the original publication to preserve the integrity of the scholarly record.
Complaint Policy - Guidance Misconduct
MLTJ complies with the best practices in dealing with complaints, which are summarized in COPE’s procedure flowcharts.
Complaints about the publishing policies, procedures and actions of the publishing and editorial staff and Editors of the Journal may be transmitted in writing to editorialoffice@mltj.online and will be forwarded to the appropriate person responsible for the issue.
If complaints refer to a peer review issue the case is referred to the Editor-in-Chief (EIC) who will respond in the appropriate timeframe.
If the complaint concerns any content of the Journal with reference to incorrect information, plagiarism, copyright or any other intellectual property infringement, the Publisher and the EIC will investigate the matter and will make the necessary decisions in compliance with the recommendations of COPE.
If any complaints cannot be resolved at the Publisher’s and EIC’s level, the case is escalated to the Executive Committee of the Italian Society of Muscles, Ligaments and Tendons (I.S.Mu.L.T.) as the owner of the Journal.
If a complainant remains unhappy after what the EiC considers a definitive reply the complainant may refer to the Executive Committee of I.S.Mu.L.T. If after a decision of I.S.Mu.L.T. the issue is still unresolved, the complainant may refer to an external independent body, such as COPE.
All complaints will be acknowledged to the appropriate person within three working days from email receipt. The Journal aims to provide a definitive response within two weeks. If more time is required by the actual circumstances, an interim response will be given within the abovementioned timeframe, until the complaint is resolved.